These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 215979)

  • 1. Inheritance of endogenous hypertriglyceridaemia type IIB or IV.
    Nikkilä EA; Aro A
    Postgrad Med J; 1975; 51(8):suppl 32-6. PubMed ID: 215979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inheritance of endogenous hypertriglyceridaemia type IIB or IV.
    Nikkilä EA; Aro A
    Postgrad Med J; 1975; 51(8):32-6. PubMed ID: 176638
    [No Abstract]   [Full Text] [Related]  

  • 3. [The familial incidence of various types of hyperlipoproteinaemia (author's transl)].
    Rudas B; Marktl W; Swoboda W
    Wien Klin Wochenschr; 1977 May; 89(11):376-8. PubMed ID: 878478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
    Miyake N; Iizuka K
    Rinsho Byori; 2002 Jun; 50(6):605-12. PubMed ID: 12166081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia.
    Sigurdsson G; Nicoll A; Lewis B
    Eur J Clin Invest; 1976 Mar; 6(2):151-8. PubMed ID: 177294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial congenital type IIB hyperlipoproteinemia].
    Di Gruttola G; Ferrara M
    Pediatria (Napoli); 1977 Sep; 85(3):435-42. PubMed ID: 201914
    [No Abstract]   [Full Text] [Related]  

  • 10. [Moderate hypercholesterolemia in children. An index of familial pathology?].
    Ruiz Moreno M; Gutiérrez Gutiérrez MT; Rincón P; Alvarez-Sala L; Camps MT
    An Esp Pediatr; 1986 Nov; 25(5):322-8. PubMed ID: 3813224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inheritance of type-III hyperlipoproteinemia. Lipoprotein patterns in first-degree relatives.
    Vessby B; Hedstrand H; Lundin LG; Olsson U
    Metabolism; 1977 Mar; 26(3):225-54. PubMed ID: 189159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.
    Ballantyne D; Olsson AG; Carlson LA
    Atherosclerosis; 1978 May; 30(1):79-87. PubMed ID: 209798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies with 14C-cholesterol in homozygotic hyperlipemia type IIa].
    Gärtner U; Altrogge H; Sieg K; Becker K; Bläker F
    Verh Dtsch Ges Inn Med; 1975; 81():1434-8. PubMed ID: 179240
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)].
    Stähelin HB; Buchmann P; Strub P; Göschke H; Thiel G; Koller F
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1301-12. PubMed ID: 1006248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of carbohydrate, fat and total energy adjustment of Fredrickson's type IIb hyperlipoproteinaemia.
    Watermeyer GS; Manning E
    S Afr Med J; 1977 Jan; 51(3):71-3. PubMed ID: 189446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthomatosis and other clinical findings in patients with elevated levels of very low density lipoproteins.
    Vermeer BJ; van Gent CM; Goslings B; Polano MK
    Br J Dermatol; 1979 Jun; 100(6):657-66. PubMed ID: 223620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.